Skip to main content

Table 2 Combined summaries of anti-malarial services provided by the public health service providers in the three study districts in Somalia

From: Health service providers in Somalia: their readiness to provide malaria case-management

 

Total

 

Hospital/MCH-OP (n = 22)

HP (n = 23)

All (n = 45)

Reported use of anti-malarials for first-line treatment*

   

   AS-SP

21 (95.5%)

0

21 (46.7%)

   SP

0

7 (30.4%)

7 (15.6%)

   Chloroquine

1 (4.5%)

16 (69.6%)

17 (37.8%)

Reported use of anti-malarials for second-line treatment**

   

   Never use

1 (4.5%)

14 (63.6%)

15 (33.3%

   Quinine

20 (91.0%)

2 (8.7%)

22 (48.9%)

   SP

1 (4.5%)

7 (30.4%)

8 (17.8%)

Nationally recommended first-line therapy in stock on day of survey***

12 (54.5%)

3 (13.0%)

15 (33.3%)

Nationally recommended second-line therapy in stock on day of survey

19 (86.4%)

0

19 (42.2%)

Parasitological diagnosis****

   

   None

2 (9.0%)

23 (100.0%)

25 (55.5%)

   RDT

20 (91.0%)

0

20 (44.4%)

   Microscopy

12 (54.5%)

0

12 (26.7%)

RDT in stock on day of survey

11 (50.0%)

0

11 (24.4%)

Revised national guidelines available at facility****

14 (63.6%)

0

14 (31.1%)

RDT use wall charts available at facility****

18 (81.8%)

0

18 (40.0%)

Anti-malarial dosing wall charts available at facility

18 (81.8%)

1 (4.3%)

19 (42.2%)

Charging for malaria consultation, diagnosis or treatment

8 (36.4%)

9 (39.1%)

17 (37.7%)

  1. HP = health post; MCH/OP = Mother and Child Health/Out-patient facility; SP = sulphadoxine-pyrimethamine; AS-SP = artesunate and SP; RDT = rapid diagnostic test
  2. *National treatment guidelines recommend AS-SP as first-line therapy in hospitals and MCH/OP facilities and SP at health posts.
  3. ** National treatment guidelines recommend Quinine as second-line therapy in hospitals and MCH/OP facilities. The guidelines also recommend that health posts refer patients to MCH/OP or hospitals in case of treatment failure with AS-SP.
  4. ***First-line drugs were considered out of stock if a hospital or MCH/OP facility did not have either AS or SP or both and if a health post did not have SP on the day of survey.
  5. ****National treatment guidelines recommend the use of RDT or microscopy for diagnosis of malaria at hospitals and MCH/OP while at health posts clinical diagnosis and presumptive treatment are recommended.